Skip to main content
Equibles
TMO logo

TMO · Thermo Fisher Scientific Inc. · Earnings Call Transcripts & Audio

Track TMO — free

Use TMO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TMO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$675.05 -4.56 (-0.67%) At close · Sep 30
S&P 500 member Russell 1000 member Rebalance outlook locked
Market Cap
$249.58B
Shares
369.75M
Volume · Sep 30 2.32M Avg daily vol (3M) 2.05M

Thermo Fisher Scientific Inc. Earnings Call Transcripts

Quarterly earnings calls for Thermo Fisher Scientific Inc. (TMO), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲7% $11.45B $1.57B '22 Q4 23-02-01 ▼9.4% $10.71B $1.29B '23 Q1 23-04-26 ▼2.6% $10.69B $1.36B '23 Q2 23-07-26 ▼1% $10.57B $1.70B '23 Q3 23-10-25 ▼4.9% $10.89B $1.65B '23 Q4 24-01-31 ▼3.4% $10.35B $1.33B '24 Q1 24-04-24 ▼1.4% $10.54B $1.55B '24 Q2 24-07-24 ▲0.2% $10.60B $1.63B '24 Q3 24-10-23 ▲4.7% $11.39B $1.83B '24 Q4 25-01-30 ▲0.2% $10.36B $1.51B '25 Q1 25-04-23 ▲3% $10.86B $1.62B '25 Q2 25-07-23 ▲4.9% $11.12B $1.62B '25 Q3 25-10-22 ▲7.2% $12.21B $1.96B '25 Q4 26-01-29 ▲6.2% $11.01B $1.65B '26 Q1 26-04-23 LATEST ▲10.5% $11.99B $1.74B '26 Q2 26-07-23
Earnings call
FY26 · Q3
2026-10-21
Thermo Fisher Scientific Inc. (TMO) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-15
Thermo Fisher Scientific Inc. (TMO) September 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-07-23
Thermo Fisher Scientific Inc. (TMO) Q2 2026 Earnings Call Transcript
Confident tone Quarterly financial results End market performance Bioproduction and clinical research (PPD/Clario)
Revenue
$11.99B
▲ 10.5% YoY
Diluted EPS
$4.68
▲ 9.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Capital Markets Day
Investor event
2026-05-20
Thermo Fisher Scientific Inc. (TMO) May 2026 Capital Markets Day Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-23
Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript
Positive tone Strategic collaborations and M&A Quarterly financial results End market performance
Revenue
$11.01B
▲ 6.2% YoY
Diluted EPS
$4.43
▲ 11.3% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-01-29
Thermo Fisher Scientific Inc. (TMO) Q4 2025 Earnings Call Transcript
Confident tone Pharma and Biotech End Market 2026 Guidance and Outlook Accelerator Drug Development / CDMO and CRO
Revenue
$12.21B*
▲ 7.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-10-22
Thermo Fisher Scientific Inc. (TMO) Q3 2025 Earnings Call Transcript
Confident tone Strategic Collaboration with OpenAI End Markets PPD and Clinical Research Services
Revenue
$11.12B
▲ 4.9% YoY
Diluted EPS
$4.27
▲ 0.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-23
Thermo Fisher Scientific Inc. (TMO) Q2 2025 Earnings Call Transcript
Positive tone Tariffs and policy environment Pharma and biotech end market Trusted partner status and PPI Business System
Revenue
$10.86B
▲ 3% YoY
Diluted EPS
$4.28
▲ 5.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-23
Thermo Fisher Scientific Inc. (TMO) Q1 2025 Earnings Call Transcript
Positive tone Q1 strong financial execution Bioproduction and pharma services demand High-impact innovation and new products
Revenue
$10.36B
▲ 0.2% YoY
Diluted EPS
$3.98
▲ 15% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-01-30
Thermo Fisher Scientific Inc. (TMO) Q4 2024 Earnings Call Transcript
Confident tone Q4 and full-year financial results Pharma services and Accelerator Drug Development China business and environment
Revenue
$11.39B*
▲ 4.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-23
Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript
Positive tone Clinical research (PPD) and CRO trends Pharma and biotech end market Quarterly financial performance and EPS guidance raise
Revenue
$10.60B
▲ 0.2% YoY
Diluted EPS
$4.25
▼ 3.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Thermo Fisher Scientific Inc. (TMO) Q2 2024 Earnings Call Transcript
Confident tone PPI business system and operational execution End market performance Customer partnerships and commercial expansion
Revenue
$10.54B
▼ 1.4% YoY
Diluted EPS
$4.04
▲ 15.1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-24
Thermo Fisher Scientific Inc. (TMO) Q1 2024 Earnings Call Transcript
Confident tone Quarterly financial performance China and Biosecure Act risk Raised guidance
Revenue
$10.35B
▼ 3.4% YoY
Diluted EPS
$3.46
▲ 4.2% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-31
Thermo Fisher Scientific Inc. (TMO) Q4 2023 Earnings Call Transcript
Positive tone Q4 and full year financial results PPI business system and operational discipline China market outlook and Biosecure Act
Revenue
$10.89B*
▼ 4.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-10-25
Thermo Fisher Scientific Inc. (TMO) Q3 2023 Earnings Call Transcript
Revenue
$10.57B
▼ 1% YoY
Diluted EPS
$4.42
▲ 16.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-26
Thermo Fisher Scientific Inc. (TMO) Q2 2023 Earnings Call Transcript
Revenue
$10.69B
▼ 2.6% YoY
Diluted EPS
$3.51
▼ 16.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-26
Thermo Fisher Scientific Inc. (TMO) Q1 2023 Earnings Call Transcript
Revenue
$10.71B
▼ 9.4% YoY
Diluted EPS
$3.32
▼ 40.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-01
Thermo Fisher Scientific Inc. (TMO) Q4 2022 Earnings Call Transcript
Revenue
$11.45B*
▲ 7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-10-26
Thermo Fisher Scientific Inc. (TMO) Q3 2022 Earnings Call Transcript
Revenue
$10.68B
▲ 14.4% YoY
Diluted EPS
$3.79
▼ 20.9% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Thermo Fisher Scientific Inc. (TMO) Q2 2022 Earnings Call Transcript
Revenue
$10.97B
▲ 18.3% YoY
Diluted EPS
$4.22
▼ 8.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Thermo Fisher Scientific Inc. (TMO) Q1 2022 Earnings Call Transcript
Revenue
$11.82B
▲ 19.3% YoY
Diluted EPS
$5.61
▼ 4.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-02
Thermo Fisher Scientific Inc. (TMO) Q4 2021 Earnings Call Transcript
Revenue
$10.70B*
▲ 1.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-10-27
Thermo Fisher Scientific Inc. (TMO) Q3 2021 Earnings Call Transcript
Revenue
$9.33B
▲ 9.5% YoY
Diluted EPS
$4.79
▼ 1% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-07-28
Thermo Fisher Scientific Inc. (TMO) Q2 2021 Earnings Call Transcript
Revenue
$9.27B
▲ 34.1% YoY
Diluted EPS
$4.61
▲ 59% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Thermo Fisher Scientific Inc. (TMO) Q1 2021 Earnings Call Transcript
Revenue
$9.91B
▲ 59% YoY
Diluted EPS
$5.88
▲ 198.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-01
Thermo Fisher Scientific Inc. (TMO) Q4 2020 Earnings Call Transcript
Revenue
$10.55B*
▲ 54.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-21
Thermo Fisher Scientific Inc. (TMO) Q3 2020 Earnings Call Transcript
Revenue
$8.52B
▲ 35.9% YoY
Diluted EPS
$4.84
▲ 157.4% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-06
Thermo Fisher Scientific Inc. (TMO) Q2 2020 Earnings Call Transcript
Revenue
$6.92B
▲ 9.5% YoY
Diluted EPS
$2.90
▲ 4.7% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-04-06
Thermo Fisher Scientific Inc. (TMO) Q1 2020 Earnings Call Transcript
Revenue
$6.23B
▲ 1.7% YoY
Diluted EPS
$1.97
▼ 2.5% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-01-30
Thermo Fisher Scientific Inc. (TMO) Q4 2019 Earnings Call
Revenue
$6.83B
▲ 4.9% YoY
Diluted EPS
$2.49
▲ 12.2% YoY
Gross margin
44.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–30 of 30 earnings calls
Key facts CIK 97745 CUSIP 883556102 13F (30d) 60 filings 32 filers Visit website Investor relations